Overlapping public health crises during the coronavirus disease pandemic

[...]patients presenting with respiratory complaints including electronic cigarette (e-cigarette) or vaping product use-associated lung injury (EVALI) could be assumed to have SARS-CoV-2 (unless proven otherwise) because this is the most readily available explanation. [4,5,6] Accordingly, the Centers for Disease Control and Prevention (CDC) of the USA issued a health alert urging the importance of healthcare providers asking patients with symptoms consistent with EVALI about e-cigarette use or vaping (especially from teenagers and young adults) during SARS-CoV-2 evaluations. [7] Confirming a diagnosis of EVALI has been difficult because there has been no simple lab-test to do so. [...]current diagnoses are largely based on patient-reported symptoms, recent vaping product use, lung computed tomography (CT) scan abnormalities, and absence of infection. [15] It should be noted that radiologists are familiar with the unique imaging and clinical characteristics. [...]radiologists are well-positioned for an initial diagnosis and to help ED physicians expedite treatment decisions to ensure the best patient outcome.